ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Shares Sold by Griffin Asset Management Inc.

Griffin Asset Management Inc. reduced its position in shares of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) by 15.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,120 shares of the company’s stock after selling 1,638 shares during the period. Griffin Asset Management Inc. owned 0.18% of ALPS Medical Breakthroughs ETF worth $288,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. UBS Group AG increased its position in ALPS Medical Breakthroughs ETF by 1.5% during the second quarter. UBS Group AG now owns 263,853 shares of the company’s stock worth $9,530,000 after purchasing an additional 3,937 shares during the last quarter. Morgan Stanley increased its position in shares of ALPS Medical Breakthroughs ETF by 4.7% during the second quarter. Morgan Stanley now owns 236,280 shares of the company’s stock valued at $8,534,000 after acquiring an additional 10,506 shares during the last quarter. Bank of America Corp DE increased its position in shares of ALPS Medical Breakthroughs ETF by 1.3% during the second quarter. Bank of America Corp DE now owns 186,922 shares of the company’s stock valued at $6,751,000 after acquiring an additional 2,405 shares during the last quarter. Advisory Services Network LLC increased its position in shares of ALPS Medical Breakthroughs ETF by 21.0% during the second quarter. Advisory Services Network LLC now owns 78,533 shares of the company’s stock valued at $2,837,000 after acquiring an additional 13,622 shares during the last quarter. Finally, Cardan Capital Partners LLC increased its position in shares of ALPS Medical Breakthroughs ETF by 13.0% during the second quarter. Cardan Capital Partners LLC now owns 55,527 shares of the company’s stock valued at $2,006,000 after acquiring an additional 6,403 shares during the last quarter.

Shares of SBIO traded up $0.39 during trading on Tuesday, reaching $36.00. 139 shares of the company traded hands, compared to its average volume of 36,565. ALPS Medical Breakthroughs ETF has a twelve month low of $25.49 and a twelve month high of $37.40. The stock has a 50-day simple moving average of $33.49 and a 200-day simple moving average of $34.43.

Featured Story: Technical Analysis of Stocks, How Can It Help

Want to see what other hedge funds are holding SBIO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO).

Institutional Ownership by Quarter for ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)

Receive News & Ratings for ALPS Medical Breakthroughs ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Medical Breakthroughs ETF and related companies with MarketBeat.com's FREE daily email newsletter.